Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag, Gilles Salles, Bertrand Coiffier et al.|The Lancet|2016

Cited by 190